Search Results - "Liao, Ross"

Refine Results
  1. 1

    Lineage plasticity and treatment resistance in prostate cancer: the intersection of genetics, epigenetics, and evolution by Imamura, Jarrell, Ganguly, Shinjini, Muskara, Andrew, Liao, Ross S, Nguyen, Jane K, Weight, Christopher, Wee, Christopher E, Gupta, Shilpa, Mian, Omar Y

    Published in Frontiers in endocrinology (Lausanne) (30-06-2023)
    “…Androgen deprivation therapy is a cornerstone of treatment for advanced prostate cancer, and the development of castrate-resistant prostate cancer (CRPC) is…”
    Get full text
    Journal Article
  2. 2

    Comparison of Pathological Stage in Patients Treated with and without Neoadjuvant Chemotherapy for High Risk Upper Tract Urothelial Carcinoma by Liao, Ross S., Gupta, Mohit, Schwen, Zeyad R., Patel, Hiten D., Kates, Max, Johnson, Michael H., Hahn, Noah M., McConkey, David, Bivalacqua, Trinity J., Pierorazio, Phillip M.

    Published in The Journal of urology (01-07-2018)
    “…High risk upper tract urothelial carcinoma has been associated with poor survival outcomes. Limited retrospective data support neoadjuvant chemotherapy prior…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Androgen receptor-mediated non-genomic regulation of prostate cancer cell proliferation by Liao, Ross S, Ma, Shihong, Miao, Lu, Li, Rui, Yin, Yi, Raj, Ganesh V

    Published in Translational andrology and urology (01-09-2013)
    “…Androgen receptor (AR)-mediated signaling is necessary for prostate cancer cell proliferation and an important target for therapeutic drug development…”
    Get full text
    Journal Article
  5. 5

    Contemporary Management of Bulbar Urethral Strictures by Liao, Ross S, Stern, Erica, Wright, James E, Cohen, Andrew J

    Published in Reviews in urology (2020)
    “…Urethral stricture disease (USD) is a progressive scar-forming disease commonly encountered by urologists and is challenging to manage. USD most frequently…”
    Get full text
    Journal Article
  6. 6

    Interview date trends for dermatology residency from 2012-2017 by Kwon, Christina D, Liao, Ross S, Young, Patrick J, Lee, Andrew H, Zuo, Rena C, Yi, Paul H, Grossberg, Anna L

    Published in Dermatology online journal (15-05-2019)
    “…Data regarding dermatology residency interview patterns can better inform applicants regarding the application process as well as encourage further…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10

    I dream of Gini: Quantifying inequality in otolaryngology residency interviews by Lee, Andrew H., Young, Patrick, Liao, Ross, Yi, Paul H., Reh, Douglas, Best, Simon R.

    Published in The Laryngoscope (01-03-2019)
    “…Objectives Otolaryngology applicants routinely decry conflicting interview dates because this limits the number of interviews that one can attend, despite…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    The risk of prostate cancer diagnosis in men with an elevated PSA but low IsoPSA by Abdallah, Nour, Benidir, Tarik, Wood, Andrew, Lone, Zaeem M, Campbell, Rebecca, Zhang, Ao, Ergun, Onuralp, Curry, Caleb, Liao, Ross, Michael, Patrick, Haywood, Samuel, Schwen, Zeyad, Olivares, Ruben, Kaouk, Jihad, Abouassaly, Robert, Klein, Eric A., Weight, Christopher

    Published in Journal of clinical oncology (01-02-2024)
    “…292 Background: IsoPSA is a structure-based serum assay. Initial studies demonstrated that it outperformed total and percent-free PSA in detecting clinically…”
    Get full text
    Journal Article
  17. 17

    Abstract 4501: Loss of miR-21 delays myc-driven prostate cancer progression in the hi-myc transgenic mouse model by Zennami, Kenji, Rafiqi, Fatima, Liao, Ross, Sealover, Kim, Simons, Brian, Sumitomo, Makoto, Shiroki, Ryoichi, Lupold, Shawn

    Published in Cancer research (Chicago, Ill.) (01-07-2019)
    “…Abstract Introduction and Objectives: MicroRNA 21 (miR-21) is overexpressed in virtually all types of cancers including prostate cancer (PCa). We have…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    A NOVEL ORTHOTOPIC MURINE MODEL OF NEUROENDOCRINE BLADDER CANCER: INSIGHTS INTO THE MOLECULAR DRIVERS OF SMALL CELL BLADDER CANCER (SCBC) by Liao, Ross, Imamura, Jarrell, Muskara, Andrew, Ganguly, Shinjini, Balyimez, Aysegul, Ornstein, Moshe, Gupta, Shilpa, McKenney, Jesse, Klein, Eric, Weight, Chris, Almassi, Nima, Mian, Omar, McFarland, Chris

    Published in Urologic oncology (01-03-2024)
    “…SCBC is an aggressive subtype of bladder cancer with high metastatic potential and few effective therapies. The defining mutations of neuroendocrine cancers…”
    Get full text
    Journal Article